Company Filing History:
1 out of 1 
1 out of 4 Years Active: 2023
Title: The Innovations of Pinliang Hu
Introduction
Pinliang Hu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical biotechnology, particularly through his innovative work on fusion proteins. His research focuses on the treatment, prevention, and diagnosis of diseases related to interleukin-17.
Latest Patents
One of his notable patents is the "Anti-IL-17 antibody/TNFR ECD fusion protein and use thereof." This invention relates to a fusion protein that combines an anti-interleukin-17 antibody with a tumor necrosis factor receptor extracellular region. The patent also includes a polynucleotide encoding the fusion protein, a vector comprising the polynucleotide, and a host cell containing the polynucleotide or vector. This fusion protein has potential applications in treating, preventing, and diagnosing related diseases in individuals. Pinliang Hu holds 1 patent.
Career Highlights
Throughout his career, Pinliang Hu has worked with various companies, including Beijing Beyond Biotechnology Co., Ltd and Hangzhou Polymed Biopharmaceuticals, Inc. His expertise in biotechnology has allowed him to contribute to advancements in medical treatments and therapies.
Collaborations
Some of his notable coworkers include Jing Zou and Weidong Hong, who have collaborated with him on various projects in the field of biotechnology.
Conclusion
Pinliang Hu's innovative work in medical biotechnology, particularly his patent on the anti-IL-17 antibody fusion protein, showcases his commitment to advancing healthcare solutions. His contributions continue to impact the field positively.